These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 29195766

  • 1. Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.
    Neudorfer K, Schmidt-Malan SM, Patel R.
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):58-63. PubMed ID: 29195766
    [Abstract] [Full Text] [Related]

  • 2. Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16.
    Pfaller MA, Mendes RE, Duncan LR, Flamm RK, Sader HS.
    J Antimicrob Chemother; 2018 Oct 01; 73(10):2748-2756. PubMed ID: 29982565
    [Abstract] [Full Text] [Related]

  • 3. Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).
    Pfaller MA, Mendes RE, Sader HS, Castanheira M, Flamm RK.
    J Glob Antimicrob Resist; 2017 Dec 01; 11():4-7. PubMed ID: 28735053
    [Abstract] [Full Text] [Related]

  • 4. Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).
    Pfaller MA, Flamm RK, Castanheira M, Sader HS, Mendes RE.
    Int J Antimicrob Agents; 2018 Apr 01; 51(4):608-611. PubMed ID: 29277526
    [Abstract] [Full Text] [Related]

  • 5. 1,2,4-Oxadiazole antimicrobials act synergistically with daptomycin and display rapid kill kinetics against MDR Enterococcus faecium.
    Carter GP, Harjani JR, Li L, Pitcher NP, Nong Y, Riley TV, Williamson DA, Stinear TP, Baell JB, Howden BP.
    J Antimicrob Chemother; 2018 Jun 01; 73(6):1562-1569. PubMed ID: 29518208
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A, Baltch AL, Ritz WJ, Smith RP, Asperilla M.
    Chemotherapy; 1993 Jun 01; 39(5):302-9. PubMed ID: 8396526
    [Abstract] [Full Text] [Related]

  • 10. In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci.
    Arhin FF, Seguin DL, Belley A, Moeck G.
    Diagn Microbiol Infect Dis; 2017 Oct 01; 89(2):168-171. PubMed ID: 28733126
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE, Smith JR, Raut A, Rybak MJ.
    J Antimicrob Chemother; 2016 Jan 01; 71(1):152-5. PubMed ID: 26476277
    [Abstract] [Full Text] [Related]

  • 12. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
    Sandoe JA, Wysome J, West AP, Heritage J, Wilcox MH.
    J Antimicrob Chemother; 2006 Apr 01; 57(4):767-70. PubMed ID: 16464896
    [Abstract] [Full Text] [Related]

  • 13. Daptomycin: A viable therapeutic option for vancomycin-resistant enterococcal urinary-tract infections in Indian medical settings?
    Mohan B, Garg S, Appannanavar SB, Taneja N.
    Indian J Med Microbiol; 2016 Apr 01; 34(3):398-9. PubMed ID: 27514977
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS, Remschmidt C, Werner S, Behnke M, Schwab F, Werner G, Gastmeier P, Leistner R.
    Antimicrob Resist Infect Control; 2018 Apr 01; 7():133. PubMed ID: 30459945
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.